Business Wire

TX-SOFTSERVE

28.7.2020 13:02:11 CEST | Business Wire | Press release

Share
SoftServe Offers Complimentary Assessment for In-Store Social Distancing Solution

SoftServe , a leading digital authority and consulting company, is offering a complimentary assessment through September 30, 2020 for its In-Store Social Distancing Solution , a cloud-based computer vision and mobile app solution that offers retailers a 360-degree customer view through AI-powered advanced analytics to support value-led decision making through actionable insights. This solution enables stores to provide a secure shopping environment for customers and employees while remaining compliant with government mandated social distancing regulations, as well as track customer engagement to understand future buying dynamics and optimize store layouts.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200728005019/en/

Computer vision is a form of artificial intelligence (AI) that trains computers to interpret and understand digital images from cameras and videos. Computers can ‘learn’ to accurately identify and classify objects, and then react to and report on what they ‘see’. It’s a rapidly growing platform for real-time store management and enhanced operations. By 2021, 40% of retailers will implement computer vision in their customer service and support workflow, and vendors employing computer vision in retail will see a 20% lift in conversion.1

“SoftServe’s in-store social distancing solution is bridging a critical gap for retailers, ensuring a safe shopping environment through the COVID-19 pandemic while providing a valuable long-term solution for continual security, future growth, and consumer engagement,” said Valentyn Kropov, VP, client success at SoftServe. “Our solution works with your existing in-store equipment and can be ‘retrained’ around future scenarios, giving you a foundation on which to optimize store operations and customer experience for years to come.”

Ensure Customer and Employee Safety and Social Distancing Regulatory Compliance

  • Mask and Temperature Detection —detect if patrons are wearing masks and scan customers’ temperatures with an infrared thermometer upon entry.
  • Manage Store Capacity —count the number of patrons entering and exiting the store and provide entry permission alerts and QR code vouchers through a mobile app.
  • Avoid Physical Lines —track designated distance between queued customers, provide department wait times and information through digital signage, and allow patrons to reserve spots in line.

Identify and Understand Customers’ Buying Dynamics

  • Real-Time Data Processing —get actionable insights in the moment with a self-learning system that fully automates data collection.
  • In-Store Customer Tracking —understand your customers’ in-store movements and product engagement better with demographics and heatmap analysis.
  • Create More Immersive Shopping Experiences —learn customer interaction points and deploy AI-driven dynamic in-store advertisements. Use location analytics to optimize store layout and product positioning around customer preferences.

SoftServe’s In-Store Social Distancing Solution integrates with a store’s existing CCTV infrastructure and software platforms and can be rapidly deployed to be up and running in a couple of weeks. It’s designed to be scalable for hundreds of stores, yet is customizable around the specific business needs of each individual store.

Book your complimentary assessment and demo through the end of September today. Contact RetailDemo@softserveinc.com for a timely evaluation of your store environment to identify the most cost-efficient solution.

1 Nick Ingelbrecht, Anthony Bradley “Emerging Technologies: Top Advanced Computer Vision Use Cases for Retail”, Gartner, April 23, 2020

About SoftServe

SoftServe is a digital authority that advises and provides at the cutting-edge of technology. We reveal, transform, accelerate, and optimize the way enterprises and software companies do business. With expertise across healthcare, retail, energy, financial services, software, and more, we implement end-to-end solutions to deliver the innovation, quality, and speed that our clients’ users expect.

SoftServe delivers open innovation—from generating compelling new ideas, to developing and implementing transformational products and services. Our work and client experience is built on a foundation of empathetic, human-focused experience design that ensures continuity from concept to release. We empower enterprises and software companies to (re)identify differentiation, accelerate solution development, and vigorously compete in today’s digital economy. No matter where you are in your journey.

Visit our website , blog , LinkedIn , Facebook , and Twitter pages.

Link:

ClickThru

Social Media:

https://www.facebook.com/SoftServeInc

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy8.6.2026 12:00:00 CEST | Press release

Shilpa Biocare Pvt Ltd, a Subsidiary of Shilpa Medicare Limited (BSE/NSE: SHILPAMED) has entered a strategic equity partnership with Gate2Brain, S.L., a biotechnology company focused on CNS therapeutics. Shilpa becomes a strategic shareholder and CMC, manufacturing, and regulatory partner for G2B-002 — Gate2Brain's lead program targeting deadly pediatric brain cancers, DIPG and pGBM, both with Orphan Drug Designation from the US FDA and EMA. G2B-002 uses Gate2Brain's proprietary MiniAp4 peptide shuttle to deliver SN-38 across the blood-brain barrier, demonstrating up to 100-fold greater brain drug transport preclinically. First-in-human trials are anticipated by FY28. G2B-002 targets high-growth oncology markets — the glioblastoma market projected at USD 6.48B by 2035 (CAGR: 7.97%), pediatric brain tumors at USD 2.47B by 2031 (CAGR: 6.9%), and DIPG at USD 1.2B by 2035 (CAGR: 7.1%). Gate2Brain's MiniAp4 platform further extends potential across rare pediatric cancers and broader CNS cat

Haleon Invests in India to Deliver Better Everyday Health to Rural Communities8.6.2026 11:11:00 CEST | Press release

£175m for first Haleon manufacturing site in Madhya Pradesh, central IndiaFast-growing India key to Haleon reaching one billion more consumers by 2030India’s consumer health market to reach over £23bn by 20301Accelerated rural distribution to access 3 million outletsAffordable Sensodyne packs and investment to double ‘last-mile’ reach in rural areas Haleon, a consumer company that is solely focused on better everyday health, today announces plans to expand its business in India, one of its fastest-growing markets and key to Haleon delivering its strategy and ambitions to reach one billion more consumers by 2030. Haleon will invest approximately £175 million2 in building a new oral health manufacturing site in Madhya Pradesh, central India and accelerate distribution efforts in rural India to meet rising demand. The new site will also support supply for wider Asia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608753094/e

Diabetology’s Breakthrough Clinical Data From Oraglutide™ Oral GLP-18.6.2026 10:56:00 CEST | Press release

Oraglutide™ Once Weekly, Low Dose, Low side-effect, Oral GLP-1 Glucose and Insulin Response Over 6 days: Clinical Data Posted at World ADA Diabetes & Obesity Conference Diabetology Limited (Jersey) poster presentation (https://diabetology.co.uk/ada-poster) 1724-P at the ADA 86th Scientific Session, New Orleans, reporting first human data from Oraglutide™ — small capsule intestinally-released oral semaglutide, formulated using the proprietary Axcess™ delivery technology. KEY HIGHLIGHTS 6-day glucose control: A single 4 mg oral dose of Oraglutide™ produced a sustained fall in glucose. Measuring 14% at Day 6 (p=.046), the longest duration presented from a single oral GLP-1 dose in a human IVGTT study. 28% increase in insulin secretion: Relative to placebo, insulin percent AUC increased by 12% day 0, (p=0.02) & 28% Day 1 (p = 0.025). Novel intestinal depot effect: Blood levels of semaglutide were higher on Day 1 than dosing on Day 0, consistent with lipid associated depot effect in the int

Reply at VivaTech 2026: Making AI, Agents and Robotics Happen Across the Enterprise8.6.2026 10:00:00 CEST | Press release

Reply[EXM, STAR: REY] is taking part in VivaTech 2026, Europe's largest innovation and technology event, held from June 17 to 20 at Paris Expo Porte de Versailles. At the event, Reply will showcase its latest innovations around AI for software engineering, AI-powered experiences, data and AI, and industrial AI. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608667672/en/ At VivaTech 2026 Reply will showcase its latest innovations around AI for software engineering, AI-powered experiences, data and AI, and industrial AI. Industries are being reshaped by AI, autonomous agents, robotics and new digital experiences. From strategy to execution, Reply helps companies move beyond experimentation and innovative ideas into concrete business value. Visitors can meet Reply in Hall 7.1, booth 1G12, and explore how, through real use cases, scalable solutions and live demonstrations, the group makes innovation happen. This year, Reply'

Cardiolife Partners with Bhutan Ministry of Health to Strengthen Nationwide Cardiac Care8.6.2026 10:00:00 CEST | Press release

Cardiolife is proud to partner with the Ministry of Health of Bhutan to roll out its advanced AI-powered ECG diagnostics system nationwide. The collaboration will provide access to early ECG diagnosis and prevention, marking a major step forward in the country’s effort to strengthen heart health and preventive care. Bhutan has a population of just over 700,000 people and heart failure and other cardiac conditionsare among the leading causes of death. Following constructive meetings in Thimphu, His Excellency, the Health Minister, officially endorsed the national rollout of Cardiolife’s solution and expressed appreciation for Cardiolife’s commitment to advancing cardiac care through the provision of free software and ECG equipment in Bhutan. “We are grateful to the Cardiolife team for their commitment to improving heart health in Bhutan. With cardiovascular diseases on the rise, this collaboration marks an important milestone in our journey to strengthen early detection and prevention a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye